Effect of masupirdine (SUVN‐502) on cognition in patients with moderate Alzheimer's disease: A randomized, double‐blind, phase 2, proof‐of‐concept study
R. Nirogi, J. Ieni, V. Goyal, J. Ravula, S. Jetta, A. Shinde, P. Jayarajan, V. Benade, Veera Raghava Chowdary Palacharla, D. Dogiparti, V. Jasti, A. Atri, J. Cummings
Alzheimer's & Dementia